![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Ferriman D., Gallwey J. D. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 1961; 21: 1440–1447
- Hammerstein J., Meckies J., Leo-Rosberg I., Moltz L., Zielske F. Use of cyproterone acetate ICPA) in the treatment of acne, hirsutism and virilism. Journal of Steroid Biochemistry 1975; 6: 827–836
- Iqbal M. J., Johnson M. W. Study of steroid-protein binding by a novel ‘two-tier’ column employing Cibacron Blue F35-A-Sepharose 4B 1-Sex hormone binding globulin. Journal of Steroid Biochemistry 1977; 8: 977–983
- Sawers R., Iqbal M. J., Dalton M, Buratti-de Houghton R. Cyproterone acetate-ethinyl-oestradiol. Effective means of controlling androgen SHBG ratio in hirsutism. Adrenal Androgens, A. R. Genazzani, J. H. H. Thjissen, P. K. Siiteri. Raven Press, New York 1980; 295–300
- Underhill R., Dewhurst J. Further clinical experience in the treatment of hirsutism with cyproerone acetate. British Journal of Obstetrics and gynaecology 1979; 86: 139–141